<?xml version="1.0" encoding="UTF-8"?>
<p id="Par41">The trial is now closed to participant accrual, but the trial is ongoing. The endpoint assessment of all the participants will be completed by the end of August 2021. The schedule of enrollment, interventions, and assessments is presented in Table 
 <xref rid="Tab2" ref-type="table">2</xref>. The protocol has been submitted for publication after the end of recruitment due to manuscript preparation and author’s travel plan. 
</p>
